Conjunctival-limbal autograft in total unilateral limbal stem cell deficiency
Abstract
Background: The corneal epithelium is renewed by stem cells (SCs) that reside in the corneal limbus. Absence or dysfunction of limbal SCs or their niche leads to the ocular surface disease called limbal stem cell deficiency (LSCD), clinically characterized by corneal conjunctivalization, vascularization, persistent epithelial defects, chronic inflammation, and loss of vision.Total unilateral LSCD is treated by autologous transplantation of limbal epithelial stem cells (LESC) obtained from the healthy other eye.We describe the treatment of choice for unilateral LSCD, i.e. the combination of autologous limbal transplantation, called conjunctival limbal autograft (CLAU) and the use of amniotic membrane (AM). We present the results of CLAU in three patients with total unilateral LSCD due to chemical injury.
Methods: Autologous limbal transplantation CLAU begins with the removal of the fibrovascular pannus from the diseased corneal surface and the harvesting of two conjunctival-limbal grafts from the healthy eye. The grafts are then transplanted onto the limbal area of the recipient eye. AM is used as a patch to cover the denuded cornea and limbal grafts, and serves as a barrier preventing the conjunctival epithelium from encroaching onto the temporal and nasal sides of the corneal surface. In the donor eye, AM is used to cover the donor sites. The combination of CLAU and AM transplanation was used in three patients with unilateral LSCD due to chemical eye injury. In one patient, limbal transplantation was combined with symblepharon lysis for entropium repair. In all cases AM was removed three to six days postoperatively to assess the growth of new epithelium from the limbal grafts. In all patients the ocular surface was covered with another AM that was left in place until the cornea was completely epithelialized and the new epithelium stabilized. One patient required subsequent corneal regrafting and cataract removal.
Results: During the follow up period CLAU proved successful in two patients and partially successful in one patient. In all cases the growth of new epithelium from the limbal grafts was noted on days three to six after CLAU. The cornea completely epithelialized within two weeks in two patients and within 35 days in one patient. In two patients the corneal epithelium remained clear, smooth and stable during the follow up of three and a half years and four months, respectively. In one patient, uneven epithelium, probably representing a mosaic pattern of corneal and conjunctival cells, was noted in the central corneal region, where a small corneal ulcer developed five months after CLAU. In the donor eyes no postoperative complications were noted, the donor sites epithelialized within a few days.
Conclusions: Autologous limbal transplantation using the combination of CLAU and the use of AM is a successful and safe therapy for restoring corneal surface in total unilateral LSCD after chemical injury. It enables surgeons to perform further surgical procedures for restoring the vision, such as corneal transplantation and cataract surgery.
Downloads
References
Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989;57(2):201–9.
Shapiro MS, Friend J, Thoft RA. Corneal re-epithelialization from the conjunctiva. Investigative Ophthalmology & Visual Science. 1981;21(1 Pt 1):135–42.
Puangsricharern V, Tseng SC. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology. 1995;102(10):1476-85.
Dua HS, Azuara-Blanco A. Limbal stem cells of the corneal epithelium. Survey of Ophthalmology. 2000;44(5):415–25.
Bakhtiari P, Djalilian A. Update on limbal stem cell transplantation. Middle East Afr J Ophthalmol. 2010;17(1):9-14.
Shortt AJ, Secker GA, Notara MD, Limb GA, Khaw PT, Tuft SJ, et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol. 2007;52(5):483-502.
Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116(4):431-41.
Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R in De LM: Long-term restoration of damaged corneal surface with autologous cultivated corneal epithelium. Lancet. 1997;349(9057):990-3.
Baylis O, Figueiredo F, Henein C, Lako M, Ahmad S. 13 years of cultured limbal epithelial cell therapy: a review of the outcomes. J Cell Biochem. 2011;112(4):993-1002.
Kenyon KR, Tseng SC. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989;96(5):709-22; discussion 722-3.
Daya SM, Chan CC, Holland EJ; Members of The Cornea Society Ocular Surface Procedures Nomenclature Committee. Cornea Society nomenclature for ocular surface rehabilitative procedures. Cornea.2011;30(10):1115-9.
Tsubota K, Satake Y, Kaido M, Shinozaki N, Shimmura S, Bissen-Miyajima H, et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 1999;340(22):1697-703.
Solomon A, Ellies P, Anderson DF, Touhami A, Grueterich M, Espana EM, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency.Ophthalmology. 2002;109(6):1159-66.
Miri A, Al-Deiri B, Dua HS. Long-term outcomes of autolimbal and allolimbal transplants. Ophthalmology. 2010;117(6):1207-13.
Ilari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology. 2002;109(7):1278-84.
Dua HS, Azuara-Blanco A. Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br J Ophthalmol. 2000;84(3):273-8.
Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with corneal stem-cell deficiency. Br J Ophthalmol. 1999;83(4):414-9.
Dua HS. The conjunctiva in corneal epithelial wound healing. Br J Ophthalmol. 1988;82(12):1407–11.
Clinch TE, Goins KM, Cobo LM. Treatment of contact lens-related ocular surface disorders with autologous conjunctival transplantation. Ophthalmology. 1992;99(4):634-8.
Mashima Y, Yamada M, Yamada H, Tsunoda K, Arimoto M. Limbal autograft transplantations for chronic ocular surface failures. Jpn J Clin Ophthalmol. 1993;47:607–10.
Jenkins C, Tuft S, Liu C, Buckley R. Limbal transplantation in the management of chronic contact-lens-associated epitheliopathy. Eye (Lond). 1993;7(Pt 5):629-33.
Morgan S, Murray A. Limbal auto-transplantation in the acute and chronic phases of severe chemical injuries. Eye (Lond). 1996;10(Pt 3):349-54.
Miri A, Said DG, Dua HS. Donor site complications in autolimbal and living-related allolimbal transplantation. Ophthalmology. 2011;118(7):1265-71.
Chen JJ, Tseng SC: Corneal epithelial wound healing in partial limbal deficiency. Invest Ophthalmol Vis Sci. 1990;31(7):1301-14.
Ahmad S, Osei-Bempong C, Dana R, Jurkunas U. The culture and transplantation of human limbal stem cells. J Cell Physiol. 2010;225(1):15-9.
Dua HS, Miri A, Said DG. Contemporary limbal stem cell transplantation – a review. Clinical and Experimental Ophthalmology. 2010;38(2):104–17.
Liang L, Sheha H, Li J, Tseng SC. Limbal stem cell transplantation: new progresses and challenges. Eye (Lond). 2009;23(10):1946-53.
Fernandes M, Sangwan VS, Rao SK, Basti S, Sridhar MS, Bansal AK, et al. Limbal stem cell transplantation. Indian J Ophthalmol. 2004;52(1):5-22.
Meallet MA, Espana EM, Grueterich M, Ti SE, Goto E, Tseng SC. Amniotic membrane transplantation with conjunctival limbal autograft for total limbal stem cell deficiency. Ophthalmology. 2003;110(8):1585-92.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
